The MDI Biological Laboratory will sponsor a three-part lecture series for the public by the nation’s leading scientists in the field of aging research entitled “Live Longer, Live Better.” The lecture series will be held Aug. 6 through 10 at the MDI Biological Laboratory in Bar Harbor, Maine.
The MDI Biological Laboratory has announced that President Kevin Strange, Ph.D., has been awarded a five-year, $12 million National Institutes of Health (NIH) Center of Biomedical Research Excellence (COBRE) grant. The COBRE funding will support the continued growth and development of the Kathryn W. Davis Center for Regenerative Biology and Medicine, which was foun…
The unique story behind the discovery of a natural compound with the potential to trigger humans’ dormant powers of regeneration will be the subject of The President’s Distinguished Lecture, “Unlocking Our Regenerative Power: Nature’s Regeneration Drug,” to be delivered on Wednesday, July 18, by Kevin Strange, Ph.D., president of the MDI Biological Laboratory.
The MDI Biological Laboratory has announced that it received more than $70,000 in cash and in-kind awards for its inaugural “Applications of Organoid Technology” course, held May 27 through June 2 on the institution’s Bar Harbor campus.
The MDI Biological Laboratory has announced the establishment of the William Procter Scientific Innovation Fund in honor of Dr. William Procter (1873-1951), a businessman, entrepreneur and scientist. Procter’s seven-part “Biological Survey of the Mount Desert Region,” published between 1927 and 1946, has been an invaluable resource for biologists studying the fauna of the Mount Desert region.
The board of trustees and staff of the MDI Biological Laboratory are pleased to announce that Hermann Haller, M.D., has been named the next president of the 120-year-old research institution. Haller will begin his appointment on July 26, 2018.
The MDI Biological Laboratory has announced that it will offer a one-week intensive course May 27 through June 2, 2018, entitled “Applications of Organoid Technology” in partnership with Hubrecht Organoid Technology (The HUB), a non-profit organization based in Utrecht, Netherlands.
The MDI Biological Laboratory is riding the growing wave of interest in citizen science with the development of a new, easily accessible mobile phone app to help community organizations track and analyze crowd-sourced data from citizen volunteers on critical environmental questions.
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.
Coagulation Sciences LLC, a medical device startup that is being incubated at the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has selected Enercon Technologies of Gray, Maine, to be its contract manufacturing partner for its Multiple Coagulation Test SystemTM (MCTS).